BioNTech SE BNTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 1:11 PM EDT
128.50quote price arrow up+0.15 (+0.12%)
Volume
619,114
52 week range
117.08 - 369.68
Loading...
  • Open126.80
  • Day High132.50
  • Day Low126.61
  • Prev Close128.35
  • 52 Week High369.68
  • 52 Week High Date11/29/21
  • 52 Week Low117.08
  • 52 Week Low Date06/22/22

Key Stats

  • Market Cap31.186B
  • Shares Out242.69M
  • 10 Day Average Volume0.91M
  • Dividend-
  • Dividend Yield-
  • Beta0.04
  • YTD % Change-49.71

KEY STATS

  • Open126.80
  • Day High132.50
  • Day Low126.61
  • Prev Close128.35
  • 52 Week High369.68
  • 52 Week High Date11/29/21
  • 52 Week Low117.08
  • 52 Week Low Date06/22/22
  • Market Cap31.186B
  • Shares Out242.69M
  • 10 Day Average Volume0.91M
  • Dividend-
  • Dividend Yield-
  • Beta0.04
  • YTD % Change-49.71

RATIOS/PROFITABILITY

  • EPS (TTM)48.41
  • P/E (TTM)2.65
  • Fwd P/E (NTM)6.68
  • EBITDA (TTM)15.008B
  • ROE (TTM)105.30%
  • Revenue (TTM)20.534B
  • Gross Margin (TTM)81.82%
  • Net Margin (TTM)55.44%
  • Debt To Equity (MRQ)1.42%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date06/02/2022
  • Div Amount2.1322
  • Split Date-
  • Split Factor-

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Ugur Sahin M.D.
Chief Executive Officer, Member of the Management Board
Sierk Poetting
Chief Operating Officer, Member of the Management Board
Jens Holstein
Chief Financial Officer
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
MRNA
Moderna Inc
120.76-2.88-2.33%
BIIB
Biogen Inc
195.25-2.53-1.28%
ILMN
Illumina Inc
183.26-7.12-3.74%
REGN
Regeneron Pharmaceuticals Inc
684.85-12.48-1.79%
ALNY
Alnylam Pharmaceuticals Inc
198.97-1.81-0.90%